Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Shares outstanding
21,303,054 shares
Disclosed Ownership
1,192,971 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
24 Feb 2025, 17:55:38 UTC
Date of event
14 Feb 2025

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 5.6% ownership in Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") on 14 Feb 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares").
  • Disclosed ownership: 5.6%.
  • Date of event: 14 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 24 Feb 2025, 17:55.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 5.6% 1,192,971 0 1,192,971 /s/ Seth Levy Seth Levy, attorney-in-fact*
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .